Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Antel

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
European Child & Adolescent Psychiatry|March 5, 2014
Squaring the circle? On the search for circulating biomarkers in polygenic psychiatric disordersJohannes Hebebrand, Jochen Antel
Neuroscience and Biobehavioral Reviews|April 9, 2023
The role of leptin in rodent and human sleep: A transdiagnostic approach with a particular focus on anorexia nervosaJohannes Hebebrand, Saskia Denecke, Jochen Antel
European Child & Adolescent Psychiatry|October 24, 2023
Case report: clinical improvements observed in first off-label metreleptin treatment of a patient with atypical anorexia nervosaJohannes Hebebrand, Jochen Antel, Triinu Peters
Nature Reviews. Endocrinology|June 14, 2023
Could leptin substitution therapy potentially terminate entrapment in anorexia nervosa?Johannes Hebebrand, Anke Hinney, Jochen Antel
Journal of Medicinal Chemistry|July 11, 2006
CB1 cannabinoid receptor antagonists for treatment of obesity and prevention of comorbid metabolic disordersJochen Antel, Peter C Gregory, Ulrich Nordheim
Best Practice & Research. Clinical Endocrinology & Metabolism|September 27, 2014
Genes and the hypothalamic control of metabolism in humansAnke Hinney, Anna-Lena Volckmar, Jochen Antel
European Archives of Psychiatry and Clinical Neuroscience|August 24, 2014
Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?Jochen Antel, Özgür Albayrak, Gerd Heusch, et al.
Journal of Medicinal Chemistry|May 2, 2003
Design of selective peptidomimetic agonists for the human orphan receptor BRS-3Dirk Weber, Claudia Berger, Peter Eickelmann, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivativesAlessio Innocenti, Jochen Antel, Michael Wurl, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 6, 2002
Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3Dirk Weber, Claudia Berger, Timo Heinrich, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
European Child & Adolescent Psychiatry|March 5, 2014
Squaring the circle? On the search for circulating biomarkers in polygenic psychiatric disordersJohannes Hebebrand, Jochen Antel
Neuroscience and Biobehavioral Reviews|April 9, 2023
The role of leptin in rodent and human sleep: A transdiagnostic approach with a particular focus on anorexia nervosaJohannes Hebebrand, Saskia Denecke, Jochen Antel
European Child & Adolescent Psychiatry|October 24, 2023
Case report: clinical improvements observed in first off-label metreleptin treatment of a patient with atypical anorexia nervosaJohannes Hebebrand, Jochen Antel, Triinu Peters
Nature Reviews. Endocrinology|June 14, 2023
Could leptin substitution therapy potentially terminate entrapment in anorexia nervosa?Johannes Hebebrand, Anke Hinney, Jochen Antel
Journal of Medicinal Chemistry|July 11, 2006
CB1 cannabinoid receptor antagonists for treatment of obesity and prevention of comorbid metabolic disordersJochen Antel, Peter C Gregory, Ulrich Nordheim
Best Practice & Research. Clinical Endocrinology & Metabolism|September 27, 2014
Genes and the hypothalamic control of metabolism in humansAnke Hinney, Anna-Lena Volckmar, Jochen Antel
European Archives of Psychiatry and Clinical Neuroscience|August 24, 2014
Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?Jochen Antel, Özgür Albayrak, Gerd Heusch, et al.
Journal of Medicinal Chemistry|May 2, 2003
Design of selective peptidomimetic agonists for the human orphan receptor BRS-3Dirk Weber, Claudia Berger, Peter Eickelmann, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivativesAlessio Innocenti, Jochen Antel, Michael Wurl, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 6, 2002
Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3Dirk Weber, Claudia Berger, Timo Heinrich, et al.
Pageof 6